Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00735254 · ClinicalTrials.gov registry record · NA

Pulsed Dye Laser and Affirm Laser in the Treatment of Abdominoplasty Scars

A NA study, sponsored by The Cleveland Clinic.

Terminated
Registry status
NA
Development phase
3
Enrollment target

NCT00735254 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 3 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00735254, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.

TERMINATED
Registry status
NA
Development phase
3 participants
Enrollment target

Study Summary

The purpose of this study is to examine the effect of using a pulsed dye laser (the VBEAM), a non-ablative laser (the Affirm) and a combination of both lasers to improve the appearance of your surgical scar. Both the pulsed dye laser and Affirm laser are approved by the US Food and Drug Administration (FDA) for the treatment of scars. Surgical scars are a type of scar that can benefit from laser therapy. Redness and the appearance of small blood vessels near the surface of the skin (telangiectasias) develop in such scars as part of the normal healing process and usually spontaneously remit, but often slowly and incompletely. In many cases, lasers can accelerate the clearing of this redness and also improve scar texture.

Interventions

  • OTHER Placebo
  • DEVICE pulsed dye laser
  • DEVICE Affirm Laser
  • DEVICE combined PDL and Affirm Lasers

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2008-07
Est. Completion 2010-01
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT00735254

The ClinicalTrials.gov registry entry for NCT00735254 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.

NCT00735254 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00735254 about?

NCT00735254 is a clinical study titled "Pulsed Dye Laser and Affirm Laser in the Treatment of Abdominoplasty Scars". The purpose of this study is to examine the effect of using a pulsed dye laser (the VBEAM), a non-ablative laser (the Affirm) and a combination of both lasers to improve the appearance of your surgical scar. Both the pulsed dye laser and Affirm laser are approved by the US Food and Drug Administrati...

What is the current status of trial NCT00735254?

This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2008-07. Estimated completion is 2010-01.

What interventions are being tested in trial NCT00735254?

The interventions under investigation include: Placebo (OTHER), pulsed dye laser (DEVICE), Affirm Laser (DEVICE), combined PDL and Affirm Lasers (DEVICE).

Who is sponsoring clinical trial NCT00735254?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.